Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 22, 2024
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
[ Fri, Mar 22nd 2024
] - WOPRAI
Thu, March 21, 2024
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
Geulah Livshits Reiterated (TNYA) at Strong Buy and Held Target at $20 on, Mar 21st, 2024
Geulah Livshits of Chardan Capital, Reiterated "Tenaya Therapeutics, Inc." (TNYA) at Strong Buy and Held Target at $20 on, Mar 21st, 2024.
Geulah has made no other calls on TNYA in the last 4 months.
There are 3 other peers that have a rating on TNYA. Out of the 3 peers that are also analyzing TNYA, 0 agree with Geulah's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Geulah
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $18 on, Wednesday, March 20th, 2024
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $18 on, Tuesday, March 19th, 2024
- Mani Foroohar of "Leerink Partners" Initiated at Buy and Held Target at $7 on, Thursday, November 30th, 2023
